The idea that tamoxifen could encourage the growth of pre-existing end
ometrial cancer caused an increase in the screening and subsequent det
ection of endometrial cancer in tamoxifen-treated patients. These data
are biased because controls were not screened. (C) 1998 Elsevier Scie
nce Ltd. All rights reserved.